JD Stansell, DH Osmond, E Charlebois, L LaVange, JM Wallace, BV Alexander, J Glassroth, PA Kvale, MJ Rosen, LB Reichman, JR Turner and PC Hopewell
University of California, San Francisco and Los Angeles, USA.

The Pulmonary Complications of HIV Infection Study is a prospective, multicenter, observational study evaluating pulmonary disease among HIV- infected persons. For approximately 52 mo, 1,182 HIV-infected subjects were followed. All participants were evaluated for pulmonary disease on a predetermined schedule. There were 145 episodes of Pneumocystis carinii pneumonia (PCP). Low CD4 count correlated with risk of PCP (p < 0.0001); 79% had CD4 counts less than 100/microl and 95% had CD4 counts less than 200/microl. Subtle changes in diffusing capacity for carbon monoxide (DLCO) were associated with PCP. Univariate analysis identified recurrent undiagnosed fevers, night sweats, oropharyngeal thrush, and unintentional weight loss to be associated with risk among persons with CD4 counts above 200/microl. Subjects in whom CD4 counts declined to below 200/microl and who were not receiving preventive therapy were nine times more likely to develop PCP within 6 mo compared with subjects who received such therapy. A strong trend toward differences between the sexes was detected. Black subjects had less than one third the risk of developing PCP as did white subjects (p < 0.0001). There was no significant difference in risk by HIV transmission category, study site, frequency of follow-up, age, education, smoking history, or use of antiretroviral therapy. Multivariable analysis revealed low CD4 lymphocyte count (p < 0.0001), use of prophylaxis (p < 0.0001), racial differences (p < 0.0001), and declining DLCO (p = 0.015) to influence risk. Constitutional signs and symptoms indicate increased risk for PCP among HIV-infected persons with CD4 counts above 200/microl.

This article has been cited by other articles:

				X. L. Rudner, K. I. Happel, E. A. Young, and J. E. Shellito Interleukin-23 (IL-23)-IL-17 Cytokine Axis in Murine Pneumocystis carinii Infection Infect. Immun., June 1, 2007; 75(6): 3055 - 3061. [Abstract] [Full Text] [PDF]

				L. McKinley, A. J. Logar, F. McAllister, M. Zheng, C. Steele, and J. K. Kolls Regulatory T Cells Dampen Pulmonary Inflammation and Lung Injury in an Animal Model of Pneumocystis Pneumonia J. Immunol., November 1, 2006; 177(9): 6215 - 6226. [Abstract] [Full Text] [PDF]

				W.L. Ng, C.M. Chu, A.K.L. Wu, V.C.C. Cheng, and K.Y. Yuen Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus QJM, January 1, 2006; 99(1): 37 - 47. [Abstract] [Full Text] [PDF]

				M. Narasimhan, A. J. Posner, V. A. DePalo, P. H. Mayo, and M. J. Rosen Intensive Care in Patients With HIV Infection in the Era of Highly Active Antiretroviral Therapy Chest, May 1, 2004; 125(5): 1800 - 1804. [Abstract] [Full Text] [PDF]

				J. M. Beck, M. B. Blackmon, C. M. Rose, S. L. Kimzey, A. M. Preston, and J. M. Green T Cell Costimulatory Molecule Function Determines Susceptibility to Infection with Pneumocystis carinii in Mice J. Immunol., August 15, 2003; 171(4): 1969 - 1977. [Abstract] [Full Text] [PDF]

				C. Steele, M. Zheng, E. Young, L. Marrero, J. E. Shellito, and J. K. Kolls Increased Host Resistance against Pneumocystis carinii Pneumonia in {gamma}{delta} T-Cell-Deficient Mice: Protective Role of Gamma Interferon and CD8+ T Cells Infect. Immun., September 1, 2002; 70(9): 5208 - 5215. [Abstract] [Full Text] [PDF]

				L J King and S P G Padley Imaging of the thorax in AIDS Imaging, February 1, 2002; 14(1): 60 - 76. [Abstract] [Full Text] [PDF]

				R. S. Irwin and J. M. Madison Symptom Research on Chronic Cough: A Historical Perspective Ann Intern Med, May 1, 2001; 134(9_Part_2): 809 - 814. [Abstract] [Full Text] [PDF]

				J. C. L. B. de Quiros, J. M. Miro, J. M. Pena, D. Podzamczer, J. C. Alberdi, E. Martinez, J. Cosin, X. Claramonte, J. Gonzalez, P. Domingo, et al. A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis against Pneumocystis carinii Pneumonia after Highly Active Antiretroviral Therapy in Patients with HIV Infection N. Engl. J. Med., January 18, 2001; 344(3): 159 - 167. [Abstract] [Full Text] [PDF]

				J. M. Beck Pneumocystis carinii and Geographic Clustering . Evidence for Transmission of Infection Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1605 - 1606. [Full Text]

				M. N. DOHN, M. L. WHITE, E. M. VIGDORTH, C. RALPH BUNCHER, V. S. HERTZBERG, R. P. BAUGHMAN, A. GEORGE SMULIAN, and P. D. WALZER Geographic Clustering of Pneumocystis carinii Pneumonia in Patients with HIV Infection Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1617 - 1621. [Abstract] [Full Text]

				A. M. MORRIS, M. SWANSON, H. HA, and L. HUANG Geographic Distribution of Human Immunodeficiency Virus-associated Pneumocystis carinii Pneumonia in San Francisco Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1622 - 1626. [Abstract] [Full Text]

				R. Paine III, A. M. Preston, S. Wilcoxen, H. Jin, B. B. Siu, S. B. Morris, J. A. Reed, G. Ross, J. A. Whitsett, and J. M. Beck Granulocyte-Macrophage Colony-Stimulating Factor in the Innate Immune Response to Pneumocystis carinii Pneumonia in Mice J. Immunol., March 1, 2000; 164(5): 2602 - 2609. [Abstract] [Full Text] [PDF]

				P. T. DIAZ, M. A. KING, E. R. PACHT, M. D. WEWERS, J. E. GADEK, D. NEAL, H. N. NAGARAJA, J. DRAKE, and T. L. CLANTON The Pathophysiology of Pulmonary Diffusion Impairment in Human Immunodeficiency Virus Infection Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 272 - 277. [Abstract] [Full Text]